Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 AUD | 0.00% | -34.62% | -80.23% |
06-17 | Enlitic Enters New Partnerships with Esaote, Clairvo, DataFirst | MT |
06-03 | Enlitic Launches New Version of Medical Technology Software | MT |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- With regards to fundamentals, the enterprise value to sales ratio is at 2.11 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-80.23% | 9.79M | - | ||
+3.23% | 3.48B | - | - | |
+2.19% | 3.15B | - | ||
-31.67% | 1.66B | - | - | |
-30.99% | 568M | - | ||
-14.50% | 322M | - | ||
-37.86% | 268M | - | ||
-21.43% | 185M | - | - | |
-12.69% | 172M | - | ||
+6.28% | 142M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- ENL Stock
- Ratings Enlitic, Inc.